Antibodies and chimeric antigen receptors specific for CD19 Grant US-11827714-B2 United States of America 28 Nov 2023
Treatment of B cell malignancies using afucosylated pro-apoptotic anti-CD19 antibodies in… Grant US-11634488-B2 United States of America 25 Apr 2023
Antibodies to the C3D fragment of complement component 3 Grant US-RE49339-E1 United States of America 20 Dec 2022
Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profile Grant US-RE49192-E1 United States of America 30 Aug 2022
Antibodies and chimeric antigen receptors specific for CD19 Grant US-10533055-B2 United States of America 14 Jan 2020
Cell line overexpressing human CD303 antigen Application US-10239946-B2 United States of America 26 Mar 2019
Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states… Grant US-10239937-B2 United States of America 26 Mar 2019
Antibodies to the C3d fragment of complement component 3 Grant US-9815890-B2 United States of America 14 Nov 2017
Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profile Grant US-9663583-B2 United States of America 30 May 2017
Complement receptor 2 (CR2) targeting groups Grant US-9650447-B2 United States of America 16 May 2017
Anti-C3d antibody conjugates and methods of detecting complement activation Grant US-9259488-B2 United States of America 16 Feb 2016
Targeting complement factor H for treatment of diseases Grant US-9212212-B2 United States of America 15 Dec 2015
Anti-CD19 antibody having ADCC function with improved glycosylation profile Grant US-9120856-B2 United States of America 01 Sep 2015